Free Trial

Zenas BioPharma (ZBIO) Earnings Date, Estimates & Call Transcripts

Zenas BioPharma logo
$19.94 -0.46 (-2.23%)
As of 01:48 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Zenas BioPharma Earnings Summary

Zenas BioPharma issued Q4 2025 earnings on April 13, 2026, reporting an EPS of -$1.10. With a trailing EPS of -$7.81, Zenas BioPharma's earnings are expected to grow next year, from ($4.97) to ($4.55) per share.

Upcoming
Earnings Date
May. 14Before Market OpensEstimated

Q4 2025 Earnings Resources

ZBIO Upcoming Earnings

Zenas BioPharma's Q1 2026 earnings is estimated for Thursday, May 14, 2026, based on past reporting schedules

Get Zenas BioPharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Zenas BioPharma and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

ZBIO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Zenas BioPharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262-$1.30-$1.28-$1.29
Q2 20262-$1.29-$1.29-$1.29
Q3 20262-$1.28-$1.23-$1.26
Q4 20262-$1.24-$0.55-$0.90

Zenas BioPharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/14/2026
(Estimated)
--------
4/13/2026Q4 2025--$1.10--$0.98$40.00M-
3/16/2026Q4 2025-$1.22-$4.54 -$3.32-$4.54$28.75M-
11/12/2025Q3 2025-$0.87-$1.22 -$0.35-$1.22$10.00M-
8/12/2025Q2 2025-$1.02-$1.25 -$0.23-$1.25$5.00M-
5/15/2025Q1 2025-$1.15-$0.80+$0.35-$0.80$5.00M$10.00M

Data powered by Fiscal.ai.

Zenas BioPharma Earnings - Frequently Asked Questions

Zenas BioPharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 14th, 2026 based off last year's report dates. Learn more on ZBIO's earnings history.

Zenas BioPharma (NASDAQ:ZBIO) has a recorded annual revenue of $10 million.

Zenas BioPharma (NASDAQ:ZBIO) has a recorded net income of -$377.74 million. ZBIO has generated -$7.81 earnings per share over the last four quarters.

Zenas BioPharma's earnings are expected to grow from ($4.97) per share to ($4.55) per share in the next year.


This page (NASDAQ:ZBIO) was last updated on 5/12/2026 by MarketBeat.com Staff.
From Our Partners